Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Jul;12(7):2625-34.
doi: 10.1002/j.1460-2075.1993.tb05923.x.

Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src

Affiliations

Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src

G Superti-Furga et al. EMBO J. 1993 Jul.

Abstract

The protein tyrosine kinase c-Src is negatively regulated by phosphorylation of Tyr527 in its carboxy-terminal tail. A kinase that phosphorylates Tyr527, called Csk, has recently been identified. We expressed c-Src in yeast to test the role of the SH2 and SH3 domains of Src in the negative regulation exerted by Tyr527 phosphorylation. Inducible expression of c-Src in Schizosaccharomyces pombe caused cell death. Co-expression of Csk counteracted this effect. Src proteins mutated in either the SH2 or SH3 domain were as lethal as wild type c-Src, but were insensitive to Csk, even though they were substrates for Csk in vivo. Peptide binding experiments revealed that Src proteins with mutant SH3 domains adopted a conformation in which the SH2 domain was not interacting with the tail. These data support the model of an SH2 domain-phosphorylated tail interaction repressing c-Src activity, but expand it to include a role for the SH3 domain. We propose that the SH3 domain contributes to the maintenance of the folded, inactive configuration of the Src molecule by stabilizing the SH2 domain-phosphorylated tail interaction. Moreover, the system we describe here allows for further study of the regulation of tyrosine kinases in a neutral background and in an organism amenable to genetic analysis.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):627-31 - PubMed
    1. Science. 1990 Nov 16;250(4983):979-82 - PubMed
    1. Nature. 1989 Apr 6;338(6215):467 - PubMed
    1. Oncogene. 1991 Nov;6(11):2013-8 - PubMed
    1. Mol Cell Biol. 1991 Dec;11(12):5832-8 - PubMed

Publication types

MeSH terms